Continuous glucose monitors (CGMs) have become increasingly popular, no longer limited to just diabetics. This insightful narrative delves into the personal experience of an individual who, out of curiosity and a desire for better health management, began using CGMs despite not being diabetic. Initially motivated by the trend among wellness influencers and healthcare professionals, the author soon discovered the profound psychological effects these devices can induce.
The journey began with the application of a Dexcom Stelo in one arm and an Abbott Lingo in the other, both designed to track glucose levels in real-time. Although the author had no pressing medical reason to monitor glucose, the exploration aimed to assess the potential benefits for a non-diabetic user.
Over the course of a year, the author engaged in extensive research, including consultations with various doctors, testing multiple devices, and studying the science behind CGM technology. The experience revealed that while CGMs can provide valuable insights into glucose trends, they can also lead to heightened anxiety about health status. The devices, which track interstitial glucose levels, are often misinterpreted, leading the author to question their health despite normal A1C levels.
The narrative highlights a key point: the evolution of CGM technology, which transitioned from prescription-only devices for Type 1 diabetics to over-the-counter options for non-diabetics. This shift raises questions about the efficacy of CGMs for individuals without diabetes, as the author found herself caught in a cycle of anxiety over glucose readings. The pressure to maintain 'optimal' glucose levels led to an obsession with diet and exercise, with the author avoiding social situations and negotiating meals based on potential glucose spikes.
As the author navigated the complexities of CGM data interpretation, she encountered differing recommendations from healthcare professionals. While some viewed glucose spikes as normal physiological responses, others expressed concern about potential underlying issues. This lack of consensus among experts only added to the confusion and anxiety surrounding the use of CGMs.
Throughout this journey, the author experienced a range of physical and emotional challenges, including elevated morning glucose readings and subsequent visits to multiple healthcare providers. Despite receiving normal test results for diabetes, concerns regarding liver enzymes and cholesterol levels emerged, leading to additional diagnostic testing.
Ultimately, the narrative culminates in a realization: while CGMs can provide insights into metabolic health, they can also exacerbate anxiety and disordered eating patterns. The author reflects on the importance of understanding the limitations of CGMs and the potential psychological toll associated with their use. After a year of testing, the introduction of new medications finally led to improvements in health metrics, illustrating that, for some, medical intervention may be necessary to achieve optimal health outcomes.
This account serves as a cautionary tale for those considering CGM use as a means of self-optimization. It emphasizes the need for balance in health monitoring and the importance of addressing psychological well-being alongside physical health. The author concludes by advocating for informed use of CGMs, urging users to approach the technology with awareness of its limitations and potential risks.
Source: The Verge News